Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 591 JPY -6.49% Market Closed
Market Cap: 234.8B JPY
Have any thoughts about
Sumitomo Pharma Co Ltd?
Write Note

Sumitomo Pharma Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sumitomo Pharma Co Ltd
Accounts Receivables Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Accounts Receivables
ÂĄ74.1B
CAGR 3-Years
-22%
CAGR 5-Years
-9%
CAGR 10-Years
-3%
Takeda Pharmaceutical Co Ltd
TSE:4502
Accounts Receivables
ÂĄ755.4B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
6%
Daiichi Sankyo Co Ltd
TSE:4568
Accounts Receivables
ÂĄ544.5B
CAGR 3-Years
28%
CAGR 5-Years
9%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Accounts Receivables
ÂĄ530.6B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Accounts Receivables
ÂĄ239.7B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
6%
Astellas Pharma Inc
TSE:4503
Accounts Receivables
ÂĄ587.7B
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
6%

See Also

What is Sumitomo Pharma Co Ltd's Accounts Receivables?
Accounts Receivables
74.1B JPY

Based on the financial report for Jun 30, 2024, Sumitomo Pharma Co Ltd's Accounts Receivables amounts to 74.1B JPY.

What is Sumitomo Pharma Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-3%

Over the last year, the Accounts Receivables growth was -23%. The average annual Accounts Receivables growth rates for Sumitomo Pharma Co Ltd have been -22% over the past three years , -9% over the past five years , and -3% over the past ten years .

Back to Top